Syncom Formulations (India)'s Q1 FY 2025-26 Quarterly Results

Result Summary

• Syncom Formulations (India) Ltd reported a 58.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 38.8%.
• Its expenses for the quarter were up by 51.8% QoQ and 30.8% YoY.
• The net profit increased 112.8% QoQ and increased 106.4% YoY.
• The earnings per share (EPS) of Syncom Formulations (India) Ltd stood at 0.2 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Syncom Formulations (India) Ltd is a pharmaceutical company primarily engaged in the manufacturing and marketing of a wide range of pharmaceutical formulations. The company operates in the healthcare industry, focusing on the production of various medicinal products. Syncom Formulations has an extensive portfolio that includes tablets, capsules, injectables, and liquid orals. While specific recent developments were not available, the company continues to focus on expanding its market presence and product offerings within the pharmaceutical sector.

Revenue

For Q1FY26, Syncom Formulations (India) Ltd reported total income of ₹122.94 crores, showing a significant quarter-over-quarter (QoQ) increase of 58.3% from Q4FY25. Year-over-year (YoY), the total income rose by 38.8% compared to Q1FY25. These figures indicate a robust growth in revenue generation capabilities over both the quarter and the year. The increase in revenue may be reflective of enhanced sales performance or an expanded product portfolio, although specific factors contributing to this growth were not detailed in the provided data.

Profitability

In Q1FY26, the company achieved a profit before tax of ₹20.29 crores, which represents a substantial QoQ increase of 102.3% compared to Q4FY25 and a YoY increase of 100.9% from Q1FY25. The profit after tax for the quarter was ₹15.75 crores, marking a 112.8% increase QoQ and a 106.4% increase YoY. The earnings per share (EPS) also doubled to ₹0.20 in Q1FY26 from ₹0.10 in both the previous quarter and the same quarter last year. The significant rise in profitability metrics indicates improved financial performance over the periods analyzed.

Operating Metrics

Total expenses for Q1FY26 amounted to ₹102.68 crores, increasing by 51.8% QoQ from Q4FY25 and by 30.8% YoY compared to Q1FY25. The tax expense for Q1FY26 was ₹4.54 crores, which was 72.6% higher QoQ and 83.8% higher YoY. These increases in expenses and tax obligations are consistent with the overall growth in revenue and profitability, revealing an expansion in operational activities. Despite the rise in expenses, the company maintained strong profit margins, as evidenced by the higher profitability figures recorded during the period.